Shorla Oncology

Series-B+
shorlaoncology.com Biotech & Healthcare
Total Funding $35M
Latest Round $35M Series-B+
Last Announced Oct 4, 2023
Investors Undisclosed
Decision Makers 3 Verified

About Shorla Oncology

We develop and commercialize innovative oncology products for women’s and pediatric cancers. Our oncology solutions deliver life-saving treatments to patients across the world

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website shorlaoncology.com
Domain Registered Date Dec 2, 2020

Social & Network Presence

X / Twitter Profile @ShorlaOncology (187 followers) Created on Jan 2021
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $35,000,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    X account created (@ShorlaOncology)

    187 followers

  3. Milestone

    Website domain registered

    shorlaoncology.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Shorla Oncology.

Funding History

1 Round
Series-B+ · Oct 4, 2023

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts